Change

In € millions

 

2002

 

20031

 

2004

 

20052

 

2006

 

2007

 

20083

 

2009

 

2010

 

2011

1

The 2002–2003 figures have not been restated to IFRS accounting standards.

2

The 2002–2005 figures have not been restated for the Organon BioSciences divestment.

3

Continuing operations from ICI are included as from 2008. The 2008 figures have not been restated for the National Starch divestment.

Intangible assets

 

629

 

590

 

448

 

488

 

682

 

669

 

7,172

 

7,388

 

7,308

 

7,392

Property, plant and equipment

 

4,402

 

3,967

 

3,535

 

3,432

 

3,346

 

2,203

 

3,357

 

3,474

 

3,384

 

3,705

Financial non-current assets

 

2,217

 

1,866

 

1,418

 

1,800

 

1,706

 

1,402

 

1,848

 

1,783

 

1,977

 

2,198

Total non-current assets

 

7,248

 

6,423

 

5,401

 

5,720

 

5,734

 

4,274

 

12,377

 

12,645

 

12,669

 

13,295

Inventories

 

2,206

 

2,133

 

1,978

 

1,987

 

2,042

 

1,177

 

1,781

 

1,441

 

1,678

 

1,924

Receivables

 

2,815

 

2,671

 

2,761

 

2,910

 

2,919

 

2,164

 

2,977

 

2,666

 

2,896

 

3,015

Cash and cash equivalents

 

520

 

727

 

1,811

 

1,486

 

1,871

 

11,628

 

1,595

 

2,128

 

2,851

 

1,635

Assets held for sale

 

 

 

 

322

 

219

 

 

4

 

 

 

Total current assets

 

5,541

 

5,531

 

6,550

 

6,705

 

7,051

 

14,969

 

6,357

 

6,235

 

7,425

 

6,574

Shareholders’ equity

 

2,098

 

2,502

 

2,605

 

3,415

 

4,144

 

11,032

 

7,463

 

7,775

 

8,984

 

9,212

Minority interests

 

137

 

140

 

140

 

161

 

119

 

97

 

450

 

470

 

525

 

531

Total equity

 

2,235

 

2,642

 

2,745

 

3,576

 

4,263

 

11,129

 

7,913

 

8,245

 

9,509

 

9,743

Provisions

 

3,855

 

3,333

 

2,877

 

2,210

 

2,132

 

1,598

 

2,072

 

1,919

 

1,855

 

1,717

Long-term borrowings

 

2,797

 

2,717

 

2,392

 

2,702

 

2,551

 

1,954

 

2,341

 

3,641

 

2,880

 

3,035

Other non-current liabilities

 

513

 

590

 

200

 

183

 

181

 

133

 

715

 

674

 

589

 

567

Total non-current liabilities

 

7,165

 

6,640

 

5,469

 

5,095

 

4,864

 

3,685

 

5,128

 

6,234

 

5,324

 

5,319

Short-term borrowings

 

979

 

441

 

560

 

357

 

410

 

1,635

 

1,338

 

384

 

907

 

494

Current liabilities

 

2,410

 

2,231

 

2,677

 

2,571

 

2,652

 

2,276

 

3,510

 

3,220

 

3,761

 

3,762

Current portion of provisions

 

 

 

500

 

766

 

571

 

518

 

845

 

797

 

593

 

551

Liabilities held for sale

 

 

 

 

60

 

25

 

 

 

 

 

Total current liabilities

 

3,389

 

2,672

 

3,737

 

3,754

 

3,658

 

4,429

 

5,693

 

4,401

 

5,261

 

4,807

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Invested capital

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Of consolidated companies

 

8,692

 

8,117

 

7,145

 

8,007

 

8,060

 

5,197

 

13,424

 

11,732

 

12,718

 

13,708

Of investments in associates and joint ventures

 

491

 

353

 

318

 

301

 

177

 

142

 

201

 

176

 

175

 

198

Operating working capital

 

 

 

 

 

 

 

 

 

 

 

 

 

2,359

 

1,691

 

2,016

 

2,196

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

689

 

581

 

551

 

514

 

371

 

359

 

534

 

513

 

534

 

708

Depreciation

 

622

 

599

 

540

 

528

 

349

 

330

 

453

 

424

 

435

 

451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue/invested capital

 

1.55

 

1.56

 

1.68

 

1.68

 

1.85

 

1.91

 

1.07

 

1.06

 

1.15

 

1.15

Equity/non-current assets

 

0.31

 

0.41

 

0.51

 

0.62

 

0.74

 

2.60

 

0.64

 

0.65

 

0.75

 

0.73

Inventories and receivables/current liabilities

 

2.08

 

2.15

 

1.77

 

1.90

 

1.87

 

1.47

 

1.36

 

1.28

 

1.22

 

1.31

Operating working capital as % of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

16.5

 

13.7

 

13.9

 

14.4

Keyword Search
Copyright © 2012 Akzo Nobel N.V.